These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 27595147)

  • 1. Effect of the CRF
    Epstein DH; Kennedy AP; Furnari M; Heilig M; Shaham Y; Phillips KA; Preston KL
    Psychopharmacology (Berl); 2016 Dec; 233(23-24):3921-3932. PubMed ID: 27595147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The corticotropin releasing hormone-1 (CRH1) receptor antagonist pexacerfont in alcohol dependence: a randomized controlled experimental medicine study.
    Kwako LE; Spagnolo PA; Schwandt ML; Thorsell A; George DT; Momenan R; Rio DE; Huestis M; Anizan S; Concheiro M; Sinha R; Heilig M
    Neuropsychopharmacology; 2015 Mar; 40(5):1053-63. PubMed ID: 25409596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CRF1 Antagonist Verucerfont in Anxious Alcohol-Dependent Women: Translation of Neuroendocrine, But not of Anti-Craving Effects.
    Schwandt ML; Cortes CR; Kwako LE; George DT; Momenan R; Sinha R; Grigoriadis DE; Pich EM; Leggio L; Heilig M
    Neuropsychopharmacology; 2016 Nov; 41(12):2818-2829. PubMed ID: 27109623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pexacerfont as a CRF1 antagonist for the treatment of withdrawal symptoms in men with heroin/methamphetamine dependence: a randomized, double-blind, placebo-controlled clinical trial.
    Morabbi MJ; Razaghi E; Moazen-Zadeh E; Safi-Aghdam H; Zarrindast MR; Vousoghi N; Akhondzadeh S
    Int Clin Psychopharmacol; 2018 Mar; 33(2):111-119. PubMed ID: 29064909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Don't stress about CRF: assessing the translational failures of CRF
    Spierling SR; Zorrilla EP
    Psychopharmacology (Berl); 2017 May; 234(9-10):1467-1481. PubMed ID: 28265716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder.
    Coric V; Feldman HH; Oren DA; Shekhar A; Pultz J; Dockens RC; Wu X; Gentile KA; Huang SP; Emison E; Delmonte T; D'Souza BB; Zimbroff DL; Grebb JA; Goddard AW; Stock EG
    Depress Anxiety; 2010 May; 27(5):417-25. PubMed ID: 20455246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of bed nucleus of the stria terminalis corticotrophin-releasing factor receptors in frustration stress-induced binge-like palatable food consumption in female rats with a history of food restriction.
    Micioni Di Bonaventura MV; Ciccocioppo R; Romano A; Bossert JM; Rice KC; Ubaldi M; St Laurent R; Gaetani S; Massi M; Shaham Y; Cifani C
    J Neurosci; 2014 Aug; 34(34):11316-24. PubMed ID: 25143612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anxiogenic drug yohimbine reinstates palatable food seeking in a rat relapse model: a role of CRF1 receptors.
    Ghitza UE; Gray SM; Epstein DH; Rice KC; Shaham Y
    Neuropsychopharmacology; 2006 Oct; 31(10):2188-96. PubMed ID: 16341025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticotropin-Releasing Factor receptor 1 (CRF1) antagonism in patients with alcohol use disorder and high anxiety levels: effect on neural response during Trier Social Stress Test video feedback.
    Lee MR; Rio D; Kwako L; George DT; Heilig M; Momenan R
    Neuropsychopharmacology; 2023 Apr; 48(5):816-820. PubMed ID: 36564531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Both corticotropin-releasing factor receptor type 1 and type 2 are involved in stress-induced inhibition of food intake in rats.
    Sekino A; Ohata H; Mano-Otagiri A; Arai K; Shibasaki T
    Psychopharmacology (Berl); 2004 Oct; 176(1):30-8. PubMed ID: 15071721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothalamic CRF1 receptor mechanisms are not sufficient to account for binge-like palatable food consumption in female rats.
    Micioni Di Bonaventura MV; Ubaldi M; Giusepponi ME; Rice KC; Massi M; Ciccocioppo R; Cifani C
    Int J Eat Disord; 2017 Oct; 50(10):1194-1204. PubMed ID: 28833350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonism of corticotropin-releasing factor CRF
    Ferrer-Pérez C; Reguilón MD; Manzanedo C; Aguilar MA; Miñarro J; Rodríguez-Arias M
    Eur J Pharmacol; 2018 Mar; 823():87-95. PubMed ID: 29391155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRF1 and CRF2 receptors in the bed nucleus of the stria terminalis modulate the cardiovascular responses to acute restraint stress in rats.
    Oliveira LA; Almeida J; Benini R; Crestani CC
    Pharmacol Res; 2015; 95-96():53-62. PubMed ID: 25829333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicity of Pexacerfont, a Corticotropin-Releasing Factor Type 1 Receptor Antagonist, in Rats and Dogs.
    White MR; Graziano MJ; Sanderson TP
    Int J Toxicol; 2019; 38(2):110-120. PubMed ID: 30760067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of expectations in the effect of food cue exposure on intake.
    Kemps E; Herman CP; Hollitt S; Polivy J; Prichard I; Tiggemann M
    Appetite; 2016 Aug; 103():259-264. PubMed ID: 27120095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wanting and liking: Separable components in problematic eating behavior?
    Polk SE; Schulte EM; Furman CR; Gearhardt AN
    Appetite; 2017 Aug; 115():45-53. PubMed ID: 27840087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CP-154,526, a selective, non-peptide antagonist of the corticotropin-releasing factor1 receptor attenuates stress-induced relapse to drug seeking in cocaine- and heroin-trained rats.
    Shaham Y; Erb S; Leung S; Buczek Y; Stewart J
    Psychopharmacology (Berl); 1998 May; 137(2):184-90. PubMed ID: 9630005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonism of corticotrophin-releasing factor type 1 receptors attenuates caloric intake of free feeding subordinate female rhesus monkeys in a rich dietary environment.
    Moore CJ; Johnson ZP; Higgins M; Toufexis D; Wilson ME
    J Neuroendocrinol; 2015 Jan; 27(1):33-43. PubMed ID: 25674637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stress and central Urocortin increase anxiety-like behavior in the social interaction test via the CRF1 receptor.
    Gehlert DR; Shekhar A; Morin SM; Hipskind PA; Zink C; Gackenheimer SL; Shaw J; Fitz SD; Sajdyk TJ
    Eur J Pharmacol; 2005 Feb; 509(2-3):145-53. PubMed ID: 15733549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CRF1 receptor mediates the excitatory actions of corticotropin releasing factor (CRF) in the developing rat brain: in vivo evidence using a novel, selective, non-peptide CRF receptor antagonist.
    Baram TZ; Chalmers DT; Chen C; Koutsoukos Y; De Souza EB
    Brain Res; 1997 Oct; 770(1-2):89-95. PubMed ID: 9372207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.